Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
06 November 2024
Name: | PSIVIDA CORP. (PVA) |
Date of Listing: | 12 June 2008 |
Date of Delisting: | 07 May 2018 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 07 May 2018.Legal Status:
ACN: 130 843 177
Registration Date: 29 April 2008
Deregistration Date: 28 May 2019
Capital Gains Tax (CGT) Status:
This entity was deregistered on 28 May 2019. Deregistration is a Capital Gains Tax Event. In our opinion you are entitled to crystallise any capital loss in the tax year that deregistration occurs providing you have not previously done so. If you did not crystallise your loss in the tax year the entity was deregistered, you may seek to re-open that year’s assessment but anyway should seek professional advice as to how best to proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
REGISTRY:
Computershare Perth
Level 17, 221 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
company deregistered today | 28/05/2019 |
delisted from the close of trading on Monday, 07 May 2018 pursuant to Listing rule 17.11. | 07/05/2018 |
we understand the company delisted because of a significant decrease in the proportion of the Company's Common Stock held by CDI holders, poor liquidity on the ASX, spending of about AUD100,000 a year on maintaining its listing on the ASX as a result of both direct and indirect costs and further fundraising will be more likely to be successful if the Company is not listed on the ASX (the company now called EyePoint Pharmaceuticals, Inc. trades on Nasdaq as "EYPT") | 07/05/2018 |
The securities of EyePoint Pharmaceuticals, Inc (formally pSivida Corp) will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company pursuant to the announcement dated 4 April 2018, pending delisting of the Company from the official list at the close of trade on Monday, 7 May 2018. | 30/04/2018 |
The suspension of trading in the securities of EyePoint Pharmaceuticals, Inc (formally pSivida Corp) will be lifted immediately, following the release of the Company's response to an ASX price and volume query. | 26/04/2018 |
The company issues a response to ASX Price and Volume Query. | 26/04/2018 |
The securities of EyePoint Pharmaceuticals, Inc (formally pSivida Corp) will be suspended from quotation immediately, in accordance with Listing Rule 17.3. The securities will remain suspended until ASX receives a response to its price and volume query. | 26/04/2018 |
the Company has changed its name to EyePoint Pharmaceuticals, Inc. and, as part of the name change, the Company's ticker symbol on the Nasdaq Global Market ("NASDAQ") has been changed from "PSDV" to "EYPT" effective on and from 2 April 2018. Trading of shares of the Company's common stock ("Common Stock") on the NASDAQ will be unaffected by the name and ticker symbol changes and will continue during and after the ASX delisting process. The Company's ASX ticker symbol, PVA, will remain unchanged | 29/03/2018 |
listed entity carried for record purposes only - we understand that shareholders in pSivida Limited received one CDI in pSivida Corp for every 40 shares they held | 12/06/2008 |
company deregistered today | 28/05/2019 |
delisted from the close of trading on Monday, 07 May 2018 pursuant to Listing rule 17.11. | 07/05/2018 |
we understand the company delisted because of a significant decrease in the proportion of the Company's Common Stock held by CDI holders, poor liquidity on the ASX, spending of about AUD100,000 a year on maintaining its listing on the ASX as a result of both direct and indirect costs and further fundraising will be more likely to be successful if the Company is not listed on the ASX (the company now called EyePoint Pharmaceuticals, Inc. trades on Nasdaq as "EYPT") | 07/05/2018 |
The securities of EyePoint Pharmaceuticals, Inc (formally pSivida Corp) will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company pursuant to the announcement dated 4 April 2018, pending delisting of the Company from the official list at the close of trade on Monday, 7 May 2018. | 30/04/2018 |
The suspension of trading in the securities of EyePoint Pharmaceuticals, Inc (formally pSivida Corp) will be lifted immediately, following the release of the Company's response to an ASX price and volume query. | 26/04/2018 |
The company issues a response to ASX Price and Volume Query. | 26/04/2018 |
The securities of EyePoint Pharmaceuticals, Inc (formally pSivida Corp) will be suspended from quotation immediately, in accordance with Listing Rule 17.3. The securities will remain suspended until ASX receives a response to its price and volume query. | 26/04/2018 |
the Company has changed its name to EyePoint Pharmaceuticals, Inc. and, as part of the name change, the Company's ticker symbol on the Nasdaq Global Market ("NASDAQ") has been changed from "PSDV" to "EYPT" effective on and from 2 April 2018. Trading of shares of the Company's common stock ("Common Stock") on the NASDAQ will be unaffected by the name and ticker symbol changes and will continue during and after the ASX delisting process. The Company's ASX ticker symbol, PVA, will remain unchanged | 29/03/2018 |
listed entity carried for record purposes only - we understand that shareholders in pSivida Limited received one CDI in pSivida Corp for every 40 shares they held | 12/06/2008 |
Your browser may reflect a date of printing in American format.
DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
---|---|---|---|---|---|
01/10/2012 | Paul Hopper | On market CDI | 10,000 | $1.615 | $16,150 |
NAME | TITLE | DATE OF APPT |
---|---|---|
David Mazzo | Non Exec Chairman | 25/07/2005 |
Laurence Freedman | Vice President, General Counsel | 23/05/2006 |
Len Ross | Finance Director | 19/11/2009 |
James Barry | Director | 10/09/2014 |
Michael Rogers | Director | 27/07/2005 |
Nancy Lurker | Director, CEO | 16/09/2016 |
Jay Duker | Director | 28/09/2016 |
Douglas Godshall | Director | 07/03/2012 |
Kristine Peterson | Director | 27/06/2017 |
Brian Leedman | Investor Relations | |
Charles Baird | Local Agent | |
Lori Freedman | Company Secretary |
Date of first appointment, title may have changed.
NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
---|---|---|---|
Paul Ashton | Managing Director, CEO | 30/12/2005 | 16/09/2016 |
Peter Savas | Director | 14/07/2008 | 05/02/2016 |
Paul Hopper | Director | 09/07/2008 | 17/01/2014 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.